PMID- 26216644 OWN - NLM STAT- MEDLINE DCOM- 20160418 LR - 20220410 IS - 1527-9995 (Electronic) IS - 0090-4295 (Linking) VI - 86 IP - 5 DP - 2015 Nov TI - Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. PG - 1042-7 LID - S0090-4295(15)00698-6 [pii] LID - 10.1016/j.urology.2015.05.046 [doi] AB - OBJECTIVE: To assess 1-year efficacy and safety data from pilot trials of the Rezum System water vapor to treat lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: A total of 65 men with symptoms of moderate to severe BPH were enrolled in pilot studies at centers in the Dominican Republic, the Czech Republic, and Sweden. Each patient was treated with transurethral delivery of sterile water vapor (steam). International Prostate Symptom Score (IPSS), peak urinary flow (Qmax), quality of life (QoL), postvoid residual, International Index of Erectile Function, and prostate-specific antigen were evaluated at 1 week and 1, 3, 6, and 12 months post-treatment. Safety was also assessed. RESULTS: Statistically significant clinical improvements at 1, 3, 6, and 12 months were reported for IPSS (decreased by 6.8, 13.4, 13.1, and 12.5 points, respectively) and Qmax (increased by 2.0, 4.7, 4.3, and 4.6 mL/sec, respectively). At 12 months, these results equated to a 56% improvement in IPSS (P <.001) and an 87% improvement in Qmax (P <.001). QoL also improved at 12 months with a 61% improvement. Sexual function was maintained. Most of the adverse events (AEs) were related to endoscopic instrumentation and were of short duration. One case of urinary retention was classified as a procedure/device-related serious AE. CONCLUSION: The Rezum System provides effective relief of LUTS associated with BPH at 1 year. The procedure is safe with an acceptable side effect profile. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Dixon, Christopher AU - Dixon C AD - Department of Urology, Lenox Hill Hospital, New York, NY. Electronic address: cdixon3879@aol.com. FAU - Cedano, Edwin Rijo AU - Cedano ER AD - Department of Urology, Clinical Canela, La Romana, Dominican Republic. FAU - Pacik, Dalibor AU - Pacik D AD - Department of Urology, Brno University Hospital, Brno, Czech Republic. FAU - Vit, Viteslav AU - Vit V AD - Department of Urology, Brno University Hospital, Brno, Czech Republic. FAU - Varga, Gabriel AU - Varga G AD - Department of Urology, Brno University Hospital, Brno, Czech Republic. FAU - Wagrell, Lennart AU - Wagrell L AD - Urologcentrum, Stockholm, Sweden. FAU - Tornblom, Magnus AU - Tornblom M AD - Urologcentrum, Stockholm, Sweden. FAU - Mynderse, Lance AU - Mynderse L AD - Department of Urology, Mayo Clinic, Rochester, MN. FAU - Larson, Thayne AU - Larson T AD - Institute of Medical Research, Scottsdale, AZ. LA - eng PT - Clinical Trial PT - Journal Article PT - Multicenter Study DEP - 20150726 PL - United States TA - Urology JT - Urology JID - 0366151 SB - IM MH - Aged MH - Confidence Intervals MH - Follow-Up Studies MH - Humans MH - Internationality MH - Laser Therapy/*instrumentation/methods MH - Lower Urinary Tract Symptoms/etiology/physiopathology/*surgery MH - Male MH - Middle Aged MH - Minimally Invasive Surgical Procedures/methods MH - Patient Safety MH - Pilot Projects MH - Prospective Studies MH - Prostatic Hyperplasia/complications/diagnosis/*surgery MH - Recovery of Function MH - Risk Assessment MH - Severity of Illness Index MH - Transurethral Resection of Prostate/*methods MH - Treatment Outcome MH - Urodynamics EDAT- 2015/07/29 06:00 MHDA- 2016/04/19 06:00 CRDT- 2015/07/29 06:00 PHST- 2015/02/05 00:00 [received] PHST- 2015/05/14 00:00 [revised] PHST- 2015/05/22 00:00 [accepted] PHST- 2015/07/29 06:00 [entrez] PHST- 2015/07/29 06:00 [pubmed] PHST- 2016/04/19 06:00 [medline] AID - S0090-4295(15)00698-6 [pii] AID - 10.1016/j.urology.2015.05.046 [doi] PST - ppublish SO - Urology. 2015 Nov;86(5):1042-7. doi: 10.1016/j.urology.2015.05.046. Epub 2015 Jul 26.